Question 1

Who is the provider of KIM ACE Global Big Pharma ETF Units?

Accepted Answer

KIM ACE Global Big Pharma ETF Units is offered by ACE, a leading player in the field of passive investments.

Question 2

What is the ISIN of KIM ACE Global Big Pharma ETF Units?

Accepted Answer

The ISIN of KIM ACE Global Big Pharma ETF Units is KR7497510008.

Question 3

What is the Total Expense Ratio (TER) of KIM ACE Global Big Pharma ETF Units?

Accepted Answer

The total expense ratio of KIM ACE Global Big Pharma ETF Units is 0.3%, which means that investors pay 30 KRW per 10,000 KRW in investment capital annually.

Question 4

What currency is KIM ACE Global Big Pharma ETF Units listed in?

Accepted Answer

The ETF is listed in KRW.

Question 5

What additional costs can European investors incur?

Accepted Answer

European investors may incur additional costs for currency exchange and transaction fees.

Question 6

Is KIM ACE Global Big Pharma ETF Units UCITS-compliant?

Accepted Answer

No, KIM ACE Global Big Pharma ETF Units does not comply with the EU UCITS investor protection directives.

Question 7

What is the price-earnings ratio (P/E) of KIM ACE Global Big Pharma ETF Units?

Accepted Answer

The P/E ratio of KIM ACE Global Big Pharma ETF Units is 21.79.

Question 8

What index is replicated by KIM ACE Global Big Pharma ETF Units?

Accepted Answer

KIM ACE Global Big Pharma ETF Units tracks the performance of the Solactive Global Big Pharma Index - Benchmark Price Return.

Question 9

Where is KIM ACE Global Big Pharma ETF Units domiciled?

Accepted Answer

KIM ACE Global Big Pharma ETF Units is domiciled in KR.

Question 10

When was KIM ACE Global Big Pharma ETF Units launched?

Accepted Answer

The fund was launched on 11/19/2024.

Question 11

In which segment does KIM ACE Global Big Pharma ETF Units primarily invest?

Accepted Answer

The KIM ACE Global Big Pharma ETF Units mainly invests in Healthcare companies.

Question 12

What is the Net Asset Value (NAV) of KIM ACE Global Big Pharma ETF Units?

Accepted Answer

The NAV of KIM ACE Global Big Pharma ETF Units amounts to 12.86 B KRW.

Question 13

What is the Price-to-Book Ratio of KIM ACE Global Big Pharma ETF Units?

Accepted Answer

The price-to-book ratio is 7.212.

Question 14

How can I invest in this ETF?

Accepted Answer

Investments can be made through brokers or financial institutions that provide access to trading ETFs.

Question 15

How is the ETF traded?

Accepted Answer

The ETF is traded on the stock exchange, similar to stocks.

Question 16

Can I hold the ETF in my portfolio?

Accepted Answer

Yes, the ETF can be held in a regular securities account.

Question 17

Is the ETF suitable for short-term or long-term investments?

Accepted Answer

The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.

Question 18

How often is the ETF valued?

Accepted Answer

The ETF is valued on a daily stock exchange basis.

Question 19

Are there dividends for this ETF?

Accepted Answer

Information on dividends should be requested from the provider's website or your broker.

Question 20

What are the risks associated with this ETF?

Accepted Answer

The risks include market fluctuations, currency risks, and the risk associated with smaller companies.

Question 21

How transparent is the ETF regarding its investments?

Accepted Answer

The ETF is obligated to report regularly and transparently on its investments.

Question 22

How can I track the current performance of the ETF?

Accepted Answer

The performance can be viewed on Eulerpool or directly on the provider's website.

Question 23

Where can I find more information about the ETF?

Accepted Answer

Further information can be found on the official website of the provider.

KIM ACE Global Big Pharma ETF Units